|
2 Companies |
|
1 Product |
|
1 Product |
|
4 Mechanisms of Action |
|
0 Trials |
|
11 News |
|
- SAF-301 / Lysogene, Alcyone
Enrollment closed, Trial primary completion date, Gene therapy: Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy (clinicaltrials.gov) - Jan 18, 2017
P1/2, N=4, Active, not recruiting, Sponsor: LYSOGENE
Completed --> Active, not recruiting | Trial primary completion date: May 2016 --> May 2017
- SAF-301 / Lysogene, Alcyone
Trial completion, Gene therapy: Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy (clinicaltrials.gov) - Sep 7, 2016
P1/2, N=4, Completed, Sponsor: LYSOGENE
Completed --> Active, not recruiting | Trial primary completion date: May 2016 --> May 2017 Active, not recruiting --> Completed
- SAF-301 / Lysogene, Alcyone
Trial initiation date, Trial primary completion date, Gene therapy: Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy (clinicaltrials.gov) - Mar 24, 2016
P1/2, N=4, Active, not recruiting, Sponsor: LYSOGENE
Active, not recruiting --> Completed Initiation date: Oct 2013 --> May 2013 | Trial primary completion date: Jun 2017 --> May 2016
- Trial completion: Natural History Studies of Mucopolysaccharidosis III (clinicaltrials.gov) - Nov 16, 2015
P=N/A, N=25, Completed, Sponsor: Nationwide Children's Hospital
Initiation date: Oct 2013 --> May 2013 | Trial primary completion date: Jun 2017 --> May 2016 Recruiting --> Completed
- SAF-301 / Lysogene, Alcyone
Trial primary completion date, Gene therapy: Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy (clinicaltrials.gov) - Apr 14, 2015
P1/2, N=4, Active, not recruiting, Sponsor: LYSOGENE
Recruiting --> Completed Trial primary completion date: Jun 2014 --> Jun 2017
- Trial initiation date, Trial primary completion date: Natural History Studies of Mucopolysaccharidosis III (clinicaltrials.gov) - Feb 12, 2015
P=N/A, N=30, Recruiting, Sponsor: Nationwide Children's Hospital
Trial primary completion date: Jun 2014 --> Jun 2017 Initiation date: Aug 2013 --> Feb 2014 | Trial primary completion date: Jul 2015 --> Oct 2015
- Trial termination: UCBT-002: ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases (clinicaltrials.gov) - Jul 8, 2014
P3, N=40, Terminated, Sponsor: Aldagen
Initiation date: Aug 2013 --> Feb 2014 | Trial primary completion date: Jul 2015 --> Oct 2015 Suspended --> Terminated; Terminated - Sponsor Decision
- SAF-301 / Lysogene, Alcyone
New P1/2 trial, Gene therapy: Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy (clinicaltrials.gov) - Jan 30, 2014
P1/2, N=4, Active, not recruiting, Sponsor: LYSOGENE
- Enrollment open: Natural History Studies of Mucopolysaccharidosis III (clinicaltrials.gov) - Jan 14, 2014
P=N/A, N=30, Recruiting, Sponsor: Nationwide Children's Hospital
Suspended --> Terminated; Terminated - Sponsor Decision Not yet recruiting --> Recruiting
- SAF-301 / Lysogene, Alcyone
Trial completion, Gene therapy, Viral vector: Intracerebral Gene Therapy for Sanfilippo Type A Syndrome (clinicaltrials.gov) - Jul 8, 2013
P1/2, N=4, Completed, Sponsor: LYSOGENE
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- SAF-301 / Lysogene, Alcyone
New P1/2 trial, Gene therapy, Viral vector: Intracerebral Gene Therapy for Sanfilippo Type A Syndrome (clinicaltrials.gov) - Nov 16, 2011
P1/2, N=4, Completed, Sponsor: LYSOGENE